Blog
Select Health Area/Condition/Disease

NAD+ and Cancer: Current Research on Supplementation Safety and Risk
As NAD+ supplementation grows in popularity, questions about cancer risk have emerged. This article breaks down the research, highlights misleading media claims, and delves into the nuanced science...
Read more
Raising NAD+ levels with nicotinamide riboside has been shown, in animal models, to reduce pain resulting from the cancer treating drug therapy paclitaxel. When administered to rodents in combinati...
Read more